Although many cytokines are indicated to play roles in inducing or maintaining PD-L1 expression, both in vitro and in vivo studies have proved that expression of PD-L1 protein in antigen presenting cells (APCs), regulatory T lymphocytes, and cancer cells strongly relied on the existence of interferon-gamma (IFN-γ). The gene discussed is IFNG; the disease is cancer.